Navigation Links
Biotech Hall of Fame Inductees Announced
Date:10/8/2007

Ed Penhoet, Co-Founder of Chiron Corp.

He was president and CEO of the prominent biotechnology company until

May 1998. He has held leadership positions in the biotechnology

industry and in academia, and is currently vice chair of the

state-appointed board overseeing California's $3 billion stem cell

research initiative.

Hollings C. Renton, Chairman, President and CEO, Onyx Pharmaceuticals

He has served as President, Chief Executive Officer and Director of

the company since 1993. Prior to joining Onyx, Mr. Renton was the

President and Chief Operating Officer of Chiron Corporation.

Scientific Achievement

Harold E. Varmus and J. Michael Bishop

Co-recipients of the 1989 Nobel Prize in Physiology or Medicine for

their discovery of the cellular origins of retroviral oncogenes. They

directed the research that led to the discovery of proto-oncogenes --

normal genes that can be converted to cancer genes by genetic damage.

This work eventually led to the recognition that all cancer probably

arises from damage to normal genes, and provided new strategies for

the detection and treatment of cancer.

Francis Collins

Director of the National Human Genome Research Institute (NHGRI) at

the National Institutes of Health (NIH). He led the successful effort

to complete Human Genome Project (HGP), a complex multidisciplinary

scientific enterprise directed at mapping and sequencing all the human

DNA, and determining aspects of its function.

Napoleone Ferrera

Dr. Ferrara and his team of scientists at Genentech Inc. made a

groundbreaking discovery that added greatly to our understanding and

treatment of cancer. It was the identification and cloning of a gene

termed vascular endothelial growth factor, or VEG
'/>"/>

SOURCE Burrill & Company
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. The state of global biotech: An Ernst & Young perspective
2. Olympics of biotechnology has international flavor
3. Biotech officials praise focus of new venture fund
4. Getting noticed in Genetown: Wisconsin biotech on display
5. Madison biotech NimbleGen files for IPO; one of states best-funded firms
6. Wisconsin biotech firm receives $107K NIH grant
7. Biotech executive books a career flight thats closer to home
8. Manufacturing partnership will move into biotech and biomedical spaces
9. Wisconsin wont get Georgia biotech without a fight
10. The 10 biggest events shaping biotech in 2006
11. Gala Biotech among companies sold for $3.3 billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... CASTLE ROCK, Colo. , May 23, 2013 /PRNewswire/ ... vitro diagnostic company focused on obtaining FDA clearance ... APPY1 , today announced the pricing of an underwritten ... and related warrants to purchase 3,500,000 shares of its ... share at a combined public offering price of $1.25 ...
(Date:5/23/2013)... N.Y. , May 23, 2013  BioScrip, Inc. ... Company will present at the Jefferies 2013 Global Healthcare ... Grand Hyatt New York. Richard ... Hai Tran , Chief Financial Officer, ... a.m. Eastern Daylight Time.   About BioScrip ...
(Date:5/23/2013)... May 23, 2013 Can economic incentives ... work motivate members of the public to increase their ... Johns Hopkins Carey Business School Assistant Professor ... Pointing to a large body of recent research that ... May 24, 2013, issue of Science that the World ...
(Date:5/23/2013)... NY (PRWEB) May 23, 2013 ... GRAPHALLOY® self-lubricating bushings mounted in stainless steel ... self-lubricating properties of GRAPHALLOY with the application and ... Stainless Steel Pillow Blocks work exceptionally well ... corrosive or hostile liquids such as acids, alkalies, ...
Breaking Biology Technology:Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 2Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 3
... YORK, June 18 Danube Pharmaceuticals, Inc., a,privately ... development of innovative drugs for ophthalmology, is pleased,to ... MBA as its Chief,Executive Officer., "I am ... this,inflection point in its history as it advances ...
... CHESHIRE, Conn., June 18 Alexion,Pharmaceuticals, Inc. (Nasdaq: ... Officer of Alexion Pharmaceuticals, will present at the,Jefferies & ... at 4:15,p.m., ET on Wednesday, June 25, 2008., ... available live. You can,access the webcast at: http://www.alexionpharm.com ...
... N.J., June 18 HemoCue(R) AB, a,global point-of-care ... Diagnostics Incorporated (NYSE: DGX ), today announced,that ... quantitative point-of-care,test for screening for, diagnosing and monitoring ... U.S. Food and Drug Administration (FDA). With,the FDA ...
Cached Biology Technology:Barrett Katz, MD, MBA, Named CEO of Danube Pharmaceuticals 2Barrett Katz, MD, MBA, Named CEO of Danube Pharmaceuticals 3HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker 2HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker 3HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker 4HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker 5
(Date:5/23/2013)... the overall health, development, and academic success of ... ensuring that all students have opportunities to engage ... vigorous or moderate-intensity physical activity, says a new ... estimates suggest that only about half of school-age ... health and development. The report recommends that ...
(Date:5/23/2013)... palsy with autologous cord blood. Following a cardiac arrest ... had been in a persistent vegetative state with ... with the cord blood containing stem cells, the symptoms ... to speak simple sentences and to move. "Our findings, ... long-held doubts about the effectiveness of the new therapy", ...
(Date:5/23/2013)... reveal the interplay of brain chemicals which help us ... and BBSRC. , By changing the way neurons ... While these changes can affect the strength of a ... that response. , Lead author Alex Thiele, ... others, you can make yourself better heard by speaking ...
Breaking Biology News(10 mins):Schools should provide opportunities for 60 minutes of daily physical activity to all students 2Schools should provide opportunities for 60 minutes of daily physical activity to all students 3First successful treatment of pediatric cerebral palsy with autologous cord blood 2
... number of adults consuming sugar-sweetened beverages such as ... dramatically, according to a study led by researchers ... Health. Researchers examined changes over the past two ... representative survey data, and found that sugar-sweetened beverages ...
... University of Queensland could contribute to the development of ... Dengue fever. Led by Associate Professor Alexander ... Molecular and Microbial Sciences identified a novel characteristic of ... The team found all flaviviruses produced a small ...
... lead to a radical re-thinking about how the snowy ... of the adult females that we followed in a ... on the Arctic sea ice," said Universit Laval doctoral ... Gauthier as part of an International Polar Year (IPY) ...
Cached Biology News:Sweetened beverage consumption increases in the US 2UQ research targets West Nile virus and dengue fever 2Snowy owl -- a marine species? 2
The Hybrid Hunter Yeast Two-Hybrid System uses the activation of reporter genes to indicate positive protein-protein interactions. Two reporters are used an auxotrophic marker and lacZ....
Mus musculus MARCKS-like protein, mRNA...
Tris-Hepes kit of BG-163 & BG-165 (order number BG-166)...
... NEW HandyStep electronic from BRAND adds ... It is the only electronic, motor-driven ... syringe tips, including BRAND PD-Tip syringe ... Fisherbrand Dispenser Tips,and VWRbrand Combi-Syringes. Select ...
Biology Products: